140 related articles for article (PubMed ID: 661315)
1. A radioimmunoassay for serum medroxyprogesterone acetate.
Shrimanker K; Saxena BN; Fotherby K
J Steroid Biochem; 1978 Apr; 9(4):359-63. PubMed ID: 661315
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay for medroxyprogesterone acetate (Provera) using the 11alpha-hydroxy succinyl conjugate.
Royer ME; Ko H; Campbell JA; Murray HC; Evans JS; Kaiser DG
Steroids; 1974 May; 23(5):713-30. PubMed ID: 4365969
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay for serum medroxyprogesterone acetate in Thai women receiving injectable DMPA contraceptive.
Werawatgoompa S; Pongpradit T; Leepipatpaiboon S; Sukanthanak A
Contraception; 1979 Oct; 20(4):319-27. PubMed ID: 509958
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of different doses of Depo Provera.
Fotherby K; Koetsawang S; Mathrubutham M
Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
[TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate in human serum.
Mathrubutham M; Fotherby K
J Steroid Biochem; 1981 Aug; 14(8):783-6. PubMed ID: 6457936
[TBL] [Abstract][Full Text] [Related]
7. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera.
Mora G; Johansson ED
Contraception; 1976 Sep; 14(3):343-50. PubMed ID: 824097
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
10. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
Petta CA; Faundes A; Dunson TR; Ramos M; DeLucio M; Faundes D; Bahamondes L
Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
[TBL] [Abstract][Full Text] [Related]
11. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
12. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
Laatikainen T; Nieminen U; Adlercreutz H
Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
[TBL] [Abstract][Full Text] [Related]
13. A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.
Fotherby K; Saxena BN; Shrimanker K; Hingorani V; Takker D; Diczfalusy E; Landgren BM
Fertil Steril; 1980 Aug; 34(2):131-9. PubMed ID: 7409232
[TBL] [Abstract][Full Text] [Related]
14. A case for concern?
Gartland A
Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
[TBL] [Abstract][Full Text] [Related]
15. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea.
Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO
Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303
[TBL] [Abstract][Full Text] [Related]
16. Treatment of breast cancer with medroxyprogesterone acetate.
Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
[TBL] [Abstract][Full Text] [Related]
17. A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma.
Sall S; DiSaia P; Morrow CP; Mortel R; Prem K; Thigpen T; Creasman W
Am J Obstet Gynecol; 1979 Nov; 135(5):647-50. PubMed ID: 507117
[TBL] [Abstract][Full Text] [Related]
18. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
Warren MP; Mathews JH; Morishima A; Vande Wiele R
Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
[TBL] [Abstract][Full Text] [Related]
19. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
Petta CA; Faúndes A; Dunson TR; Ramos M; DeLucio M; Faúndes D; Bahamondes L
Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
[TBL] [Abstract][Full Text] [Related]
20. Treatment of seizures with medroxyprogesterone acetate: preliminary report.
Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC
Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]